| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23,8 M € | +5.2% | 22,6 M € | +13.7% | 19,9 M € | -15.6% | 23,6 M € | -1.6% | 24,0 M € | +1.4% | 23,6 M € | +35.3% | 17,5 M € | -3.2% | 18,1 M € | +4.7% | 17,2 M € | +13.7% | 15,2 M € | -7.2% | 16,3 M € | +14.2% | 14,3 M € | -29.1% | 20,2 M € | -2.8% | 20,8 M € | +21.2% | 17,1 M € | +61.1% | 10,6 M € | +8.4% | 9,8 M € | +10.2% | 8,9 M € | +3.5% | 8,6 M € | +12.7% | 7,6 M € | |
| EBITDA | -601,3 k € | +7.1% | -647,2 k € | -66.1% | -389,7 k € | -142.9% | 907,8 k € | -55.9% | 2,1 M € | -27.4% | 2,8 M € | +26.0% | 2,3 M € | -28.9% | 3,2 M € | +5.8% | 3,0 M € | +58.2% | 1,9 M € | +43.3% | 1,3 M € | +40475.3% | -3,3 k € | -100.1% | 2,6 M € | -21.1% | 3,3 M € | +57.7% | 2,1 M € | +237.3% | 613,5 k € | -1.8% | 624,6 k € | -21.1% | 792,1 k € | +31.4% | 602,6 k € | +33.1% | 452,9 k € | |
| Operating profit | -923,9 k € | +35.6% | -1,4 M € | +13.2% | -1,7 M € | -910.5% | 204,1 k € | -82.5% | 1,2 M € | -50.0% | 2,3 M € | +31.7% | 1,8 M € | -35.6% | 2,8 M € | +10.3% | 2,5 M € | +66.0% | 1,5 M € | +46.8% | 1,0 M € | +378.0% | -368,3 k € | -115.3% | 2,4 M € | -13.0% | 2,8 M € | +48.8% | 1,9 M € | +207.0% | 604,1 k € | -2.0% | 616,7 k € | -21.3% | 783,5 k € | +32.2% | 592,6 k € | +32.6% | 446,9 k € | |
| Profit/loss | -1,4 M € | +28.8% | -1,9 M € | +8.3% | -2,1 M € | -1334.9% | -145,1 k € | -125.3% | 572,9 k € | -60.8% | 1,5 M € | +45.9% | 1,0 M € | -42.1% | 1,7 M € | +13.6% | 1,5 M € | +75.7% | 866,5 k € | +18.3% | 732,8 k € | +228.9% | -568,3 k € | -529.8% | -90,2 k € | -105.6% | 1,6 M € | +37.8% | 1,2 M € | +210.3% | 375,2 k € | -3.9% | 390,2 k € | -24.2% | 515,0 k € | +25.6% | 410,2 k € | +49.8% | 273,8 k € | |
| Equity | 1,7 M € | +6417.5% | 25,6 k € | -98.7% | 1,9 M € | -51.8% | 4,0 M € | -3.5% | 4,2 M € | +16.0% | 3,6 M € | +68.5% | 2,1 M € | +0.0% | 2,1 M € | -45.4% | 3,9 M € | +64.0% | 2,4 M € | +57.3% | 1,5 M € | +94.0% | 779,9 k € | -84.9% | 5,1 M € | -11.1% | 5,8 M € | +38.3% | 4,2 M € | +38.5% | 3,0 M € | +14.2% | 2,6 M € | +17.3% | 2,3 M € | +29.6% | 1,7 M € | +30.8% | 1,3 M € | |
| Total assets | 7,9 M € | +13.9% | 6,9 M € | -30.0% | 9,9 M € | -4.3% | 10,3 M € | -13.7% | 11,9 M € | +30.7% | 9,1 M € | +3.7% | 8,8 M € | -22.4% | 11,3 M € | +11.4% | 10,2 M € | +25.1% | 8,1 M € | +20.1% | 6,8 M € | +30.2% | 5,2 M € | -55.2% | 11,6 M € | -13.7% | 13,4 M € | +29.7% | 10,4 M € | +71.2% | 6,1 M € | +16.9% | 5,2 M € | -1.6% | 5,3 M € | +28.9% | 4,1 M € | +20.1% | 3,4 M € | |
| Cash | 786,7 k € | +33.9% | 587,5 k € | -65.6% | 1,7 M € | -20.1% | 2,1 M € | -56.2% | 4,9 M € | +16.3% | 4,2 M € | -1.1% | 4,3 M € | -34.8% | 6,5 M € | +43.0% | 4,6 M € | +129.4% | 2,0 M € | -15.6% | 2,4 M € | +86.4% | 1,3 M € | -81.6% | 6,9 M € | -17.0% | 8,3 M € | +53.6% | 5,4 M € | +154.7% | 2,1 M € | -33.3% | 3,2 M € | +9.8% | 2,9 M € | +56.6% | 1,8 M € | +58.9% | 1,2 M € | |
| Debts | 6,2 M € | -9.8% | 6,8 M € | -13.5% | 7,9 M € | +26.2% | 6,3 M € | -19.2% | 7,8 M € | +40.3% | 5,5 M € | -16.9% | 6,7 M € | -27.5% | 9,2 M € | +46.7% | 6,3 M € | +9.1% | 5,7 M € | +9.3% | 5,3 M € | +19.0% | 4,4 M € | -31.4% | 6,4 M € | -15.8% | 7,7 M € | +23.8% | 6,2 M € | +103.7% | 3,0 M € | +20.2% | 2,5 M € | -16.2% | 3,0 M € | +28.4% | 2,3 M € | +13.9% | 2,1 M € | |
| Staff | 57,1 | 55 | 54,7 | 55,5 | 58,7 | 52,5 | 57,3 | 69,2 | 65,2 | 54,8 | 38,2 | 39,1 | 36,1 | 35,2 | 29,6 | 27,3 | 24,9 | 22,3 | 19,9 | 16,7 | ||||||||||||||||||||
Public limited company · Nazareth-De Pinte · incorporated on 05/05/1959 · 57,1 ETP
Public limited company loss-making in the latest fiscal year. Cash position rising (+33.9%).
Solid counterparty for a standard engagement.
FAGRON BELGIUM is a Public limited company incorporated in 1959. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Nazareth-De Pinte. It employs on average 57,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette